SCHEMBL16804162

SCHEMBL16804162

CC(=N)CC(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL610951 0.76
SCHEMBL375346 0.72
SCHEMBL8057917 0.72 TSHR (0.44)
SCHEMBL12569640 0.71
SCHEMBL11920308 0.71 ALDH1A1 (0.30)
SCHEMBL18508411 0.71
SCHEMBL27722734 0.71
SCHEMBL6437184 0.69
Alcohol SCHEMBL28359582 0.69 ALDH1A1 (0.41)
Cyclopropane SCHEMBL28481284 0.69 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141937-A1 RETINOIC ACID RECEPTOR ANTAGONISTS AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) 2018-05-24 US disclosed
US-20170037039-A1 RETINOIC ACID RECEPTOR ANTAGONISTS AS CHAPERONE-MEDIATED AUTHOPHAGY MODULATORS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) 2017-02-09 US disclosed
US-9512092-B2 Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) 2016-12-06 US disclosed
US-20150166492-A1 RETINOIC ACID RECEPTOR ANTAGONISTS AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE 2015-06-18 US disclosed